SUGBY Financial Statements & Analysis
Complete financial statements for SUGBY including income statement, balance sheet, and cash flow statement. Analyze SUGBY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
30.7% ↑
Net Income
82.5% ↑
Gross Margin
5.8% ↑
Operating Margin
15.8% ↑
Balance Sheet
Current Ratio
198000515731179.4% ↑
Debt to Equity
0.0% ↓
Asset Turnover
27.1% ↑
Cash Flow
Operating Cash Flow
103.8% ↑
Net Cash Flow
100.0% ↑
Free Cash Flow
103.1% ↑
Cash Flow to Debt
103.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2025 | 2026 | Change | Impact |
|---|---|---|---|---|
| Revenue | 69.23B | 90.46B | 30.7% | |
| Gross Profit | 66.68B | 92.15B | 38.2% | |
| Operating Income | 24.72B | 37.41B | 51.3% | |
| Net Income | 20.18B | 36.82B | 82.5% | |
| EPS | 1098.50 | 2105.90 | 91.7% | |
| EBITDA | 30.80B | 41.71B | 35.4% | |
| Gross Margin | 96.32% | 101.87% | 5.8% | |
| Operating Margin | 35.70% | 41.35% | 15.8% | |
| Net Income Margin | 29.14% | 40.70% | 39.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 90.46B | 69.23B | 61.75B | — | — |
| Gross Profit | 92.15B | 66.68B | 61.75B | — | — |
| Operating Income | 37.41B | 24.72B | 18.26B | — | — |
| Net Income | 36.82B | 20.18B | 15.38B | — | — |
| EPS | 2105.90 | 1098.50 | 754.40 | — | — |
| EBITDA | 41.71B | 30.80B | 24.80B | — | — |
| Gross Margin | 101.87% | 96.32% | 100.00% | — | — |
| Operating Margin | 41.35% | 35.70% | 29.57% | — | — |
| Net Income Margin | 40.70% | 29.14% | 24.90% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into SUGBY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics